透云生物科技集团有限公司（01332）于2026年3月2日发布2026年2月的证券变动月报表。报告期内，公司法定股本维持在12,500,000,000股普通股，面值每股0.04港元，对应注册资本5亿港元。截至2月28日，已发行股本数量与上月底相同，维持在2,805,952,149股，库存股份为零。
根据公告，公司2月期间未有新增股份发行、购回或注销活动。公司已披露的多项股份期权计划在本月并无行使或转让，期末结存数量与上月一致，未导致已发行股份数额变化。公司同时确认已符合香港联交所的公众持股量要求。
截至2月末，公司总股本保持稳定，未发生任何增减变动。公告由公司董事王亮签署，声明所有股份发行及持股变动均遵守相关上市规则与法规的要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.